Latest News of PLSE
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans
Investors may be drawn to unprofitable companies like Pulse Biosciences due to potential high returns. However, such companies can face bankruptcy if cash burn exceeds reserves. Pulse Biosciences had ...
Pulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
Pulse Biosciences has made progress in treating Atrial Fibrillation using Nano PFA technology. Financially, they reported increased expenses in Q3 2024 but raised $60 million through a rights offering...
A US$60m drop in the market cap of Pulse Biosciences, Inc. (NASDAQ:PLSE) is not what insiders like to see after purchasing shares recently
Insiders own 70% of Pulse Biosciences, showing a strong vested interest in the company's growth. Institutional investors hold a significant portion of the stock, adding credibility. While insider owne...